Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study

Background. The benefit of a complementary fluorodeoxyglucose‐positron emission tomography (FDG‐PET) scan to standard workup for carcinoma of unknown primary (CUP) and metastatic neck lesions was prospectively studied. Methods. Sixty‐seven patients underwent standardized diagnostic workup according to national guidelines including panendoscopies, multiple mucosal biopsies, and diagnostic CT/MRI scans. Median follow‐up was 40 months (range, 2–65 months). Results. In 60 eligible patients, FDG‐PET indicated a primary tumor or metastatic disease in 30 patients (50%). Additional investigations confirmed a primary tumor in 18 patients: hypopharynx in 5, oropharynx in 5, nasopharynx in 2, lung in 1, axilla in 1, bone in 1, rectum in 1, as well as multiple metastatic lesions from CUP in 2 patients. In retrospect, MRI was able to detect 1 of the PET‐detected primaries, leading to an overall detection rate of PET of 29% in CUP. A therapeutic change of treatment was made in 25% as a consequence of FDG‐PET. PET before panendoscopy demonstrated fewer false‐positive pathological foci. Conclusion. FDG‐PET is a valuable tool in addition to conventional extensive workup in CUP and neck metastases. Consequently, FDG‐PET is now recommended as an early diagnostic modality in the workup of these patients. © 2007 Wiley Periodicals, Inc. Head Neck, 2008